Office of Pesticide Programs 21st Century Screening Assessment of Pesticides – A Regulatory View Vicki Dellarco, Ph.D. Senior Science Advisor Office of.

Slides:



Advertisements
Similar presentations
Perspectives from EPA’s Endocrine Disruptor Screening Program
Advertisements

Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
UNEP Advisory Group Meeting Geneva, Switzerland December 12, 2014
Richard A. Becker, Ph.D., D.A.B.T American Chemistry Council Arlington, Virginia Comments on “Dose Setting” EDMVS Meeting July 23-24, 2002.
Session III: Assessing Cumulative Effects of Endocrine Active Substances 9:15 - 9:30 Introduction” Rick Becker (Session Chair and Panel Moderator) 9:30.
Priority-setting for the Endocrine Disruptor Screening Program: Pesticide Active Ingredients Penelope A. Fenner-Crisp Office of Pesticide Programs U.S.
National Pesticide Program A New Toxicology Testing Paradigm: Meeting Common Needs Steven Bradbury, Director Environmental Fate and Effects Division Office.
IDENTIFICATION OF CHEMICALS OF CONCERN WITH RESPECT TO CARCINOGENICITY Vicki L. Dellarco, Ph.D. Office of Pesticide Programs U.S. Environmental Protection.
Endocrine Screening – Phase 1 TSCA 8(e) and FIFRA 6(a)(2) Requirements A. Michael Kaplan, Ph.D. December 13, 2010 A. Michael Kaplan & Associates, LLC
1 Development & Evaluation of Ecotoxicity Predictive Tools EPA Development Team Regional Stakeholder Meetings January 11-22, 2010.
ISRTP 2009 Endocrine Workshop | 9-10 September 2009 | Washington, DC.
EDSP Validation Gary E.Timm Senior Technical Advisor Office of Science Coordination and Policy U.S. Environmental Protection Agency.
Chemical Screening Programs Ted Smith Dale Phenicie.
Overview of the NRC Vision for the Future of Toxicity Testing Daniel Krewski, PhD, MHA Professor and Director McLaughlin Centre for Population Heath Risk.
Collaboration Workshop for Global Health System Strengthening Triangle Global Health Consortium 02 December 2009 Sally S. Tinkle Senior Science Advisor,
What Do Toxicologists Do?
FAO/WHO CODEX TRAINING PACKAGE
The NIH Roadmap for Medical Research
June 16-19, USEPA Cancer Guidelines: Mode of Carcinogenic Action 1 ICABR – Impacts of the Bioeconomy on Agricultural Sustainability, the Environment.
Criteria for Screens— Review of the EDSTAC Recommendations Presentation to the EDMVS July 23, 2002.
Moving Research into Practice.  Implementation is the routine use of a SHRP 2 product by users in their regular way of doing business.  Users can include.
BC Injury Prevention Strategy Working Paper for Discussion.
Food Advisory Committee Meeting December 16 and 17, 2014 Questions to the Committee Suzanne C. Fitzpatrick, PhD, DABT Senior Advisory for Toxicology Center.
The Role of Research in the Business of the Environmental Protection Agency Steven Bradbury, Director Environmental Fate & Effects Division Office of Pesticide.
Status of the U.S. Endocrine Disruptor Screening Program (EDSP) Status of the U.S. Endocrine Disruptor Screening Program (EDSP) September
VISUALIZATION OF ADVERSE EFFECT PATHWAYS Hristo Aladjov.
EDSP’s Approach to Test Protocol Validation Office of Science Coordination and Policy U.S. Environmental Protection Agency.
SMMSS - Support to Modernisation of Mongolia Standardisation System Food Chain Risk Assessment and Management - Seminar on Food Safety Ulaanbaatar / Mongolia.
Quill Law Group LLC1 EDSP Compliance Timing, Procedural and Legal Issues Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
© 2011 Underwriters Laboratories Inc. All rights reserved. This document may not be reproduced or distributed without authorization. ASSET Safety Management.
Slide 1 of 24 EPA’s Endocrine Disruptor Screening Program (EDSP) Use of Exposure Data in Priority Setting Bill Wooge Office of Science Coordination and.
1 Tier 1 EDSP: Other Scientifically Relevant Information Barbara Neal Exponent December 13, 2010.
2 n McKim Workshop on Reducing Data Redundancy in Cancer Assessment | 8 – 10 May 2012 | Baltimore, MD Highlighting the Need for AOPs in Streamlining Hazard.
Designing a QSAR for ER Binding. QSAR Xenobiotic ER Binding Altered Protein Expression Altered Hormone Levels, Ova-testis Chg 2ndry Sex Char, Altered.
Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Office of Research and Development.
Wildlife Screens What Do They Tell Us? Dr. Pat Guiney Manager Global Safety, Regulatory & Environmental Assessment S.C. Johnson & Son, Inc. Racine, WI.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
Regulatory Processes for Pesticides Mark Hartman Antimicrobials Division (AD) Office of Prevention, Pesticides and Toxic Substances United States Environmental.
International Society of Regulatory Toxicology and Pharmacology 2009 Endocrine Workshop The Endocrine Disruptor Screening Program: What Can Screening Results.
Office of Research and Development National Exposure Research Laboratory, Atmospheric Modeling and Analysis Division S.T. Rao Director, NERL/AMAD U.S.
Development of a Common Effects Methodology for OW and OPP EPA Development Team Office of Pesticide Programs Office of Water Office of Research and Development.
Communications and the Endocrine Disruptor Screening Program ISRTP Workshop December 13, 2010.
Quill Law Group LLC1 EDSP Implementation Business and Legal Considerations Terry F. Quill Quill Law Group LLC 1667 K St, NW Washington, DC
EDSP: T IER 1 T ESTING I NFORMATION C OLLECTION ISRTP 2010 Endocrine Workshop EDSP Compliance December 13, 2010 Susan Ferenc, DVM, Ph.D.
Introduction to Session II: Incorporating Existing Data into the EDSP Erik R. Janus Director, Human Health Policy CropLife America.
The McKim Conferences for the Strategic Use of Testing Gitchee Gumee Conference Center Duluth, Minnesota June 27-29, 2006.
1 Nanoscale Materials Stewardship Program Environmental Summit May 20, 2008 Jim Alwood Chemical Control Division Office of Pollution Prevention and Toxics.
OECD’s work on Adverse outcome pathways
Overview of Pesticides and Toxics Research Programs: Safe Pesticides/Safe Products and Endocrine Disruptors Elaine Z. Francis, Ph.D. National Program Director,
NUATRC/TCEQ Air Toxics Workshop October Air Toxics Air Toxics: What We Know, What we Don’t Know, and What We Need to Know Human Health Effects –
McKim Conference on Predictive Toxicology The Inn of Lake Superior Duluth, Minnesota September 16-18, 2008 Toxicity Pathways as an Organizing Concept Gilman.
McKim Workshop on Strategic Approaches for Reducing Data Redundancy in Cancer Assessment Duluth, MN, USA 19 May, 2010.
EDSP Implementation: Concerns for the Pesticide Industry ISRTP 2009 Endocrine Workshop: The Endocrine Disruptor Screening Program: What Can Screening Results.
McKim Conference on Predictive Toxicology The Inn of Lake Superior Duluth, Minnesota September 25-27, 2007 Toxicity Pathways as an Organizing Concept Gilman.
Perspective on the current state-of-knowledge of mode of action as it relates to the dose response assessment of cancer and noncancer toxicity Jennifer.
QSAR in CANCER ASSESSMENT PURPOSE and AGENDA Gilman Veith Duluth MN May 19-21, 2010.
Office of Research and Development National Center for Environmental Assessment Human Health Risk Assessment and Information for SRP July 28, 2009 Reeder.
Michael P. Holsapple, PhD, Fellow ATS HESI Executive Director Future of Chemical Toxicity Testing in the US Monday, 21 June 2010 National Press Club, Washington,
Key Concepts on Health Risk Assessment of Chemical Mixtures.
“Fit for Purpose” MOA/Human Relevance Analysis M.E. (Bette) Meek McLaughlin Centre University of Ottawa 1.
New Ecological Science Advice for Ecosystem Protection The EPA Science Advisory Board (SAB) Staff Office supports three external scientific advisory committees.
Endocrine Disruptor Screening and Testing: An Industry Update
FIFRA SAP Meeting February 2, 2010
Visualization of Adverse effect pathways
Decision Contexts in a Changing Toxicology Paradigm
EPA Experience in Problem Formulation
IDEA International Dialogue for the Evaluation of Allergens
Strategies for Integrated Human and Ecological Assessment
FQPA: “It’s a Good Thing” (for Kids)
Presentation transcript:

Office of Pesticide Programs 21st Century Screening Assessment of Pesticides – A Regulatory View Vicki Dellarco, Ph.D. Senior Science Advisor Office of Pesticide Programs US Environmental Protection Agency

Office of Pesticide Programs 1 Managing Chemical Risks Gateway to Market National Pesticide Program ~1,100 active ingredients & 19,000 products Reevaluate existing pesticides on a regular schedule Safety evaluations required for human health & ecological risks –FIFRA, FFDCA, FQPA, ESA Risk management decisions apply to –Antimicrobials, biochemical & conventional active ingredients and food-use & non-food use inert ingredients Available information –Varies across chemical programs with extensive requirements for food use, conventional pesticide actives to minimal requirements for non-food use inert ingredients

Office of Pesticide Programs 2 Managing Chemical Risks Large Number of Chemicals to Review with Many Possible Adverse Outcomes Finite Resources & Time Science Increasingly Complex & Changing Public Expectation Sound Science, Transparency & Timeliness for Environmental Health Protection Common Challenges

Office of Pesticide Programs 3 Animal Testing: Reduce, Refine, Replace 2005 OPPTS-ORD White Paper 2007 NAS Report on Testing in the 21st Century 2009 Agency’s Strategic Plan for Evaluating the Toxicity of Chemicals Use of computational tools is not new to evaluate & assign priorities for follow-up actions Managing Chemical Risks Strategic Direction Transition toward new integrative & predictive 21st century techniques, to increase efficiency and effectiveness of testing & assessment

Office of Pesticide Programs NRC 2007 “Toxicity Testing in the 21st Century: A Vision and A Strategy Objective –Foster transformative paradigm shift based largely on increased use of in vitro & in silico systems that will: broader coverage of chemicals, end points, life stages reduce cost & time of testing, increase efficiency & flexibility use fewer animals more robust scientific basis by providing mode of action & dosimetry information

Office of Pesticide Programs 5 Current Data Paradigm Cancer Reproductive Toxicity Developmental Toxicity Neurotoxicity KidneyToxicity ImmunoTox in vivo testing $Millions Food Use, Conventional Pesticide Actives: Generates in vivo animal data for all possible outcomes to determine which of all possible effects are relevant.

Office of Pesticide Programs 6 Evaluation for Relevant Effects Risk Assessment C 2 Cl 3 Cl C C 2 Cl 3 Cl C OH Cl OH Cl C 2 Cl 3 Cl C C 2 Cl 3 Cl C OH Cl OH Cl Chemical Inventories C 2 Cl 3 ClCl ClCl C ClCl ClCl C ClCl ClCl C ClCl ClCl C ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl OHOH OHOH OHOH ClCl ClCl OHOH ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl OHOH ClCl ClCl C ClCl ClCl OHOH OHOH ClCl ClCl OHOH ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl OHOH OHOH ClCl ClCl OHOH ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl OHOH ClCl ClCl OHOH OHOH OHOH ClCl ClCl OHOH ClCl ClCl OHOH OHOH ClCl ClCl OHOH ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl ClCl OHOH ClCl ClCl OHOH In Vitro Profiling: Molecular interactions, Cellular Responses Existing Knowledge, exposure use, toxicity data, SAR, QSAR Efficient Focused In Vivo Testing Priority Setting Process Research: Learn & Refine

Libraries of Toxicological Pathways Receptor/Ligand Interaction Gene Activation Protein Production Gonad Development Altered Hormone Levels Impaired Reproduction Molecular Cellular Organ Individual Chemical 3- D Structure/ Properties Chemical 2-D Structure Structure Mapping Toxicity Pathways to Adverse Outcomes

Office of Pesticide Programs 8 Managing Chemical Risks Near Term (≤5 years) Goal –Integrated Approaches to Testing & Assessment “Enhance Tool Box” - Create means to efficiently & credibly predict toxic potency & exposure levels and to focus information needs –Situations e.g., pesticide inerts, certain antimicrobials, metabolites & degradates of pesticide actives Challenge: Assessing Data-Limited Chemicals

Office of Pesticide Programs 9 Managing Chemical Risks Long Term (~15 years) –Develop means to move, in a credible & transparent manner to hypothesis & mechanism- driven, risk-based approaches that focus on effects most relevant to risk assessment & risk management “omics” technology in identifying toxicity pathways PDPK modeling Improved human exposure modeling Challenge: Reducing Uncertainty

Office of Pesticide Programs Integrated Approaches to Testing & Assessment Existing Knowledge, exposure use, toxicity data, SAR, QSAR In Vitro Profiling: Molecular interactions, Cellular Responses Efficient Focused In Vivo Testing (Q)SAR-Based System to Predict ER Binding Affinity ToxCast HTP Research Program New F1 Extended Reproductive Study Example Activities

Office of Pesticide Programs Partnerships Collaborate on development & application of predictive computational models Promote development of common databases Harmonize frameworks/guidance Build a common application tool box –OECD QSAR Tool Box Agencies & International Organizations

Office of Pesticide Programs International Partnerships Collaborate on development & application of predictive computational models –OECD Workshop (Dec 07, Wash DC) - Integrative Approaches to Testing & Assessment Build a common application tool box –OECD QSAR Tool Box Harmonize frameworks/guidance

Office of Pesticide Programs 13 Stakeholder Engagement Pesticide Program Dialogue Committee (PPDC) – Workgroup on 21st Century Toxicology/New Integrated Testing Strategies –Purpose is to advise on communication & transition Improve understanding of the perspectives of all stakeholders regarding new testing paradigm Ensure input on key science & regulatory products Develop common understanding for use of new tools

Office of Pesticide Programs Priority Setting Assay Validation Procedures US EPA EDSP Implementation 14 Selecting chemicals to be screened

Office of Pesticide Programs OECD Endocrine Testing & Assessment Conceptual Framework Level 1 - Sorting & prioritizing with existing data and/or (Q)SARs Level 2 - In vitro assays to provide mechanistic data Level 3 - In vivo assays providing data about single endocrine mechanisms & effects Level 4 - In vivo assays providing data about multiple endocrine mechanisms & effects Level 5 - In vivo assays providing data about endocrine & other effects (OECD, 2004)

Office of Pesticide Programs USEPA Endocrine Disruptor Screening & Assessment Program Sorting & Prioritizing Chemicals Tier 1 Screening –Data to determine if a chemical has the potential to interact with the estrogen, androgen or thyroid systems Tier 2 Testing –Data to determine if endocrine-mediated adverse effects occur and quantify dose-response Hazard & Risk Assessment (USEPA, 1998)

Office of Pesticide Programs Sorting Chemicals for Endocrine Disruptor Screening & Testing: Four Categories Chemicals unlikely to interact with hormone systems (e.g., certain polymers, strong mineral acids/bases) Chemicals without sufficient existing data to determine if Tier 2 testing required Chemicals with sufficient existing data to determine if Tier 2 testing required Chemicals with sufficient data to support a hazard assessment (USEPA, 1998)

Office of Pesticide Programs Prioritizing Chemicals for Endocrine Disruptor Screening & Testing Chemicals without sufficient existing data –Considered by the EDSTAC (USEPA 1998) to have the largest number of chemicals and the greatest need for prioritization –EDSTAC (USEPA, 1998) and the SAB/SAP (USEPA, 1999) strongly recommended a prioritization scheme that included an effects & exposure component

Office of Pesticide Programs Prioritizing Chemicals for Endocrine Disruptor Tier 1 Screening: Effects EDSTAC (USEPA, 1998) recommended the use of measured or predicted receptor binding and/or transcriptional activation data derived through in vitro assays/High Throughput (HTP) Screening and (Q)SARs, respectively SAB/SAP (USEPA, 1999) concurred; however, concluded that HTP screening and (Q)SARs were not sufficiently developed at that time – encouraged continued research As part of USEPA’s computational toxicology and endocrine disruptor research programs, the Office of Research and Development (ORD), in collaboration with OPP and OSCP, has been developing in vitro assays, HTPs applications & (Q)SARs

Office of Pesticide Programs (Q)SAR-Based System to Predict Estrogen Receptor Binding Affinity ORD/OPP Collaborative Effort Application for use in a prioritization scheme in the context of EDSTAC & SAB/SAP recommendations Development focused on chemicals without sufficient existing data to determine if Tier 2 testing required Model’s applicability domain – Structures associated with pesticide inert ingredients & antimicrobial pesticides

Adverse Outcome Pathway ER-mediated Reproductive Impairment QSAR focus area Inerts; Antimicrobial Chemicals Receptor Binding ER Binding Liver Cell Protein Expression Vitellogenin (egg protein transported to ovary) Liver Altered proteins(Vtg) & hormones; Gonad Ova-testis; Complete ovary in male Sex reversal; Altered behavior; Repro. In vivo MOLECULAR Target CELLULAR Response TISSUE/ORGAN INDIVIDUAL Skewed Sex Ratios; Yr Class POPULATION In vitro Assay focus area Toxicity Pathway Adverse Outcome Pathway Greater Toxicological Understanding Greater Risk Relevance

Office of Pesticide Programs (Q)SAR-Based System to Predict ER Binding Affinity External peer-review by USEPA SAP, August 2009 – html Development benefited from EDTA VMG-NA and two OECD peer consultations –May, 2008 Structural Alert Workshop mono(2009)4 –February, 2009 Expert Consultation to Evaluate an Estrogen Receptor Binding Affinity Model for Hazard Identification mono(2009)33

Office of Pesticide Programs Future Prioritization for EDSP Tier 1 Screening Inert ingredients & other chemicals –develop in vitro & in silico tools that are integrated with exposure-based metrics Pesticide active ingredients –current plan is to use EPA’s schedule for re- evaluating registered active ingredients in the Registration Review program ( Consistent with EDSTAC & SAB/SAP recommendations

Office of Pesticide Programs 24 Enhanced Integrated Testing & Assessment Where we need to be in the near term –Accelerated/enhanced priority setting/screening & focused animal testing Where we would like to be in the long term –Greater reliance on hypothesis & mechanism-based assessments What needs to happen –Collaborative research to develop scientific basis –Partnerships, stakeholder input, peer review, consensus building, staff training, development of new polices, etc